Literature DB >> 9397378

Evaluation of vancomycin use in a pediatric teaching hospital based on CDC criteria.

B A Logsdon1, K R Lee, G Luedtke, F F Barrett.   

Abstract

This study was performed to determine whether vancomycin use at our pediatric hospital was consistent with modified Centers for Disease Control and Prevention guidelines. Vancomycin use was inappropriate in 54% of patients. Inappropriate use briefly decreased by 14% after educational efforts. Further education regarding vancomycin use was deemed necessary and is continuing.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9397378     DOI： 10.1086/647539

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  3 in total

1.  Inappropriate continued empirical vancomycin use in a hospital with a high prevalence of methicillin-resistant Staphylococcus aureus.

Authors:  Nak-Hyun Kim; Hei Lim Koo; Pyoeng Gyun Choe; Pyeong Gyun Choe; Shinhye Cheon; Moonsuk Kim; Moon Suk Kim; Myung Jin Lee; Younghee Jung; Young Hee Jung; Wan Beom Park; Kyoung-Ho Song; Eu Suk Kim; Ji Hwan Bang; Hong Bin Kim; Sang Won Park; Nam Joong Kim; Myoung-don Oh; Eui Chong Kim
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

2.  Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study.

Authors:  Moacyr S Junior; Luci Correa; Alexandre R Marra; Luis F A Camargo; Carlos A P Pereira
Journal:  BMC Infect Dis       Date:  2007-08-01       Impact factor: 3.090

3.  Vancomycin-resistant enterococcus outbreak in a pediatric intensive care unit: report of successful interventions for control and prevention.

Authors:  F Carmona; S I Prado; M F I Silva; G G Gaspar; F Bellissimo-Rodrigues; R Martinez; A K Matsuno; A P C P Carlotti
Journal:  Braz J Med Biol Res       Date:  2012-01-26       Impact factor: 2.590
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.